Anthracyclines

Intervention

1 paper3 findings

MeSH D018943

  • 1 lab in 1 country
  • Funder: National University of Singapore
  • Humans1

Outcomes

3

Circulating endothelial cells

downin humans1

1 study
  1. Anthracyclines decrease circulating endothelial cells in humans.

    “CECs were highest at pre-treatment and declined significantly thereafter”

    Humanspost-treatment

    Anthracycline-mediated cardiac dysfunction: An endothelial perspective

    medRxiv4 Mar 2026Preprint

More on Circulating endothelial cells

Endothelial progenitor cells

downin humans1

1 study
  1. Anthracyclines decrease endothelial progenitor cells in humans.

    “EPCs were also highest at pre-treatment and decreased to levels below healthy controls during remission”

    Humanschildhood cancer remission

    Anthracycline-mediated cardiac dysfunction: An endothelial perspective

    medRxiv4 Mar 2026Preprint

More on Endothelial progenitor cells

Cellular senescence

upin humans1

1 study
  1. Anthracyclines increase cellular senescence in humans.

    “EPCs were predominantly senescent up to 1-year post-treatment.”

    Humanschildhood cancer remissionup to 1-year post-treatment

    Anthracycline-mediated cardiac dysfunction: An endothelial perspective

    medRxiv4 Mar 2026Preprint

More on Cellular senescence

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months